Suchergebnisse

Patent protection and FDA exclusivities are the two principal forms of protection available to companies that develop therapeutic monoclonal antibodies. Propo-sed changes to both forms of protection are currently being debated in the United States Congress. Specifically, Congress is presently debating both biosimilar and patent reform legislations. Although no bill has yet passed, it is expected that patent reform legislation should pass this year. It is less likely that a biosimilar bill will pass this year. However, when legislations are enacted, the changes will significantly impact the business of therapeutic monoclonal antibodies.

AbstractSeveral scholars have argued that abundant natural resources can be harmful to economic performance under bad institutions and helpful when institutions are good. These arguments have either been theoretical or based on naturally occurring variation in natural resource wealth. We test this theory by using a laboratory experiment to reap the benefits of randomized control. We conduct this experiment in a virtual world (Second Life™) to make institutions more visceral. We find support for the theory.

PurposeThe purpose of this paper is to introduce this special issue on "the 'new' policy partnership".Design/methodology/approachThe paper highlights the significance of policy‐academic partnerships and outlines the papers included in this issue.FindingsIt is important to form and maintain partnerships and collaborations with new nontraditional stakeholders. One place where this is evident is in academia.Originality/valueThe special issue includes original articles that address innovative ways in which researchers and policy makers can collaborate to move policy agendas forward.

Quantifying national spending on wellness and prevention / George Miller, Charles Roehrig, Paul Hughes-Cromwick, Craig Lake -- Spillover effects of prescription drug withdrawals / John Cawley, John A. Rizzo -- The psychology of nutrition messages / Heather Schofield, Sendhil Mullainathan -- Evaluation criteria for report cards of healthcare providers / Jesse D. Schold -- Evaluating the value of genomic diagnostics : implications for clinical practice and public policy / Amalia M. Issa -- Achieving the healthy people 2010 goal of elimination of health disparities : what will it take? / Kevin Fiscella -- Influence, information overload, and information technology in health care / James B. Rebitzer, Mari Rege, Christopher Shepard -- Health disparities and direct-to-consumer advertising of pharmaceutical products / Rosemary J. Avery, Donald Kenkel, Dean R. Lillard, Alan Mathios, Hua Wang -- Pharmaceutical innovation and the longevity of Australians : a first look / Frank R. Lichtenberg, Gautier Duflos -- Introduction / Lorens Helmchen, Robert Kaestner, Anthony Lo Sasso